Report Highlights
The global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Report Includes
- 170 data tables and 79 additional tables
- Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
- Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
- Analyze types of ADDS.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the advanced drug delivery systems market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||||
| Base year market size | $275.2 Billion | ||||||||||||||||||
| Market size forecast | $487.4 Billion | ||||||||||||||||||
| Growth rate | CAGR of 10.2% from 2025 to 2030 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | By Route of Administration (RoA), Technology, Application, Drug Vehicle/Carrier, and Region | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America | ||||||||||||||||||
| Countries covered | The U.S., Canada, Mexico, Brazil, Argentina, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, India, The Middle East and Africa | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
||||||||||||||||||
Frequently Asked Questions (FAQs)
- Increasing incidence of chronic diseases.
- Nanotechnology in advancing drug delivery.
- Advancements in therapeutics and material science.
- R&D spending by market players.
- Rise in government funding and pharmaceutical R&D spending.
- Route-specific barriers.
- Limitations with nanotechnology and nanoparticles.
- Challenges with nanoformulations in ADDS.
- Cost-efficiency of advanced drug delivery systems.
- Mechanism of nanoparticles in overcoming drug resistance.
- Emerging markets.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Related Reports
Global Markets for Allergy Diagnostics and Treatments
The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.
Cancer Immunotherapy: Technologies and Global Markets
The global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.
Global Injectable Drug Delivery Devices Market
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Oncology Biosimilars Market
The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2030.
Global Markets and Technologies for Advanced Drug Delivery Systems - Focus on Routes of Administration
The global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
Global GLP-1 Analogues Market
This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
Immunotherapy Drugs: Global Markets
The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.
Global Artificial Intelligence (AI) in Clinical Trials Market
The global market for Artificial Intelligence (AI) in Clinical Trials was valued at $2 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $6.5 billion by 2030, at a compound annual growth rate (CAGR) of 22.6% from 2025 through 2030.
Top Trending Reports
Global GLP-1 Analogues Market
This report presents detailed information on glucagon-like peptide-1 (GLP-1) analogues. It examines market trends for GLP-1 analogues using data from 2024, estimates for 2025, and projected compound annual growth rates (CAGRs) through 2030 (the forecast period of 2025–2030). The report also covers regional markets for GLP-1 analogues. The GLP-1 analogue market is segmented by route of administration into oral and injection. By region, the market is divided into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
Data Center Networking Technologies: Global Markets
The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.
Botanical and Plant-derived Drugs: Global Markets
The global market for botanical and plant-derived drugs is expected to grow from $38.7 billion in 2025 and is projected to reach $58.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.5% during the forecast period of 2025 to 2030.
Biofuels: Global Markets
The global market for biofuels is expected to grow from $150.9 billion in 2025 to reach $194.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Protein Expression: Global Markets
The global market for protein expression is estimated to grow from $4.7 billion in 2025 to reach $7.9 billion by 2030, at a compound annual growth rate (CAGR) of 10.9% from 2025 through 2030.
Report Highlights
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Report Includes
- An overview of the global market for drug delivery systems, with a focus on routes of administration.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018.
- Discussion of the current state, setbacks, innovations, and the future needs of the market.
- Analyses of the regulatory environment and the technology involved, including the latest developments.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More